| 27/01/25 | STX | 07:00:07 | 27 Jan 2025 | | STX | Anders Lundstrom appointed CEO | Shield Therapeutics PLC | RNS |
| 24/12/24 | STX | 11:25:00 | 24 Dec 2024 | | STX | Result of General Meeting & Total Voting Rights | Shield Therapeutics PLC | RNS |
| 23/12/24 | STX | 07:00:05 | 23 Dec 2024 | | STX | Results of RetailBook Offer | Shield Therapeutics PLC | RNS |
| 06/12/24 | STX | 11:31:00 | 6 Dec 2024 | | STX | RetailBook Offer | Shield Therapeutics PLC | RNS |
| 06/12/24 | STX | 11:30:00 | 6 Dec 2024 | | STX | Subscription by AOP Health to raise US$10 million | Shield Therapeutics PLC | RNS |
| 21/11/24 | STX | 07:00:06 | 21 Nov 2024 | | STX | Business Update | Shield Therapeutics PLC | RNS |
| 29/10/24 | STX | 07:00:07 | 29 Oct 2024 | | STX | Q3 Trading Update | Shield Therapeutics PLC | RNS |
| 25/09/24 | STX | 07:00:02 | 25 Sept 2024 | | STX | Results from Phase 3 paediatric study | Shield Therapeutics PLC | RNS |
| 04/09/24 | STX | 07:00:08 | 4 Sept 2024 | | STX | Interim results | Shield Therapeutics PLC | RNS |
| 27/08/24 | STX | 07:00:07 | 27 Aug 2024 | | STX | ACCRUFeR® Approved by Health Canada | Shield Therapeutics PLC | RNS |
| 14/08/24 | STX | 07:00:11 | 14 Aug 2024 | | STX | Notice of interim results | Shield Therapeutics PLC | RNS |
| 24/07/24 | STX | 07:01:01 | 24 Jul 2024 | | STX | Unaudited Q2 2024 Trading Update | Shield Therapeutics PLC | RNS |
| 24/07/24 | STX | 07:00:10 | 24 Jul 2024 | | STX | Directorate Change | Shield Therapeutics PLC | RNS |
| 03/07/24 | STX | 07:00:09 | 3 Jul 2024 | | STX | $5.7m Milestone Monetization Agreement with AOP | Shield Therapeutics PLC | RNS |
| 20/06/24 | STX | 16:25:41 | 20 Jun 2024 | | STX | Results of 2024 Annual General Meeting | Shield Therapeutics PLC | RNS |
| 28/05/24 | STX | 07:00:17 | 28 May 2024 | | STX | New Drug Application for Accrufer® in South Korea | Shield Therapeutics PLC | RNS |
| 10/05/24 | STX | 15:30:18 | 10 May 2024 | | STX | Audited results for the year ended 31 Dec 2023 | Shield Therapeutics PLC | RNS |
| 30/04/24 | STX | 07:00:11 | 30 Apr 2024 | | STX | Business Update for Q1 2024 | Shield Therapeutics PLC | RNS |
| 16/04/24 | STX | 07:00:13 | 16 Apr 2024 | | STX | Notice of Results | Shield Therapeutics PLC | RNS |
| 21/02/24 | STX | 07:00:06 | 21 Feb 2024 | | STX | Unaudited Full Year Trading Update | Shield Therapeutics PLC | RNS |
| 09/01/24 | STX | 07:00:04 | 9 Jan 2024 | | STX | Appointment of new Chief Financial Officer | Shield Therapeutics PLC | RNS |
| 07/12/23 | STX | 07:00:07 | 7 Dec 2023 | | STX | Q3 2023 U.S. Commercial Highlights | Shield Therapeutics PLC | RNS |
| 27/11/23 | STX | 17:24:38 | 27 Nov 2023 | | STX | PDMR Transaction Notification | Shield Therapeutics PLC | RNS |
| 20/10/23 | STX | 11:45:00 | 20 Oct 2023 | | STX | Abstract to be presented at Healthcare Conference | Shield Therapeutics PLC | RNS |
| 12/10/23 | STX | 07:00:09 | 12 Oct 2023 | | STX | Chief Financial Officer Transition | Shield Therapeutics PLC | RNS |
| 03/10/23 | STX | 15:00:01 | 3 Oct 2023 | | STX | Result of REX Retail Offer | Shield Therapeutics PLC | RNS |
| 03/10/23 | STX | 07:00:09 | 3 Oct 2023 | | STX | Block listing Interim Return | Shield Therapeutics PLC | RNS |
| 03/10/23 | STX | 07:00:06 | 3 Oct 2023 | | STX | Completion of SWK Financing | Shield Therapeutics PLC | RNS |
| 28/09/23 | STX | 12:50:02 | 28 Sept 2023 | | STX | Successful completion of US$6.1m Equity Fundraise | Shield Therapeutics PLC | RNS |
| 28/09/23 | STX | 07:02:02 | 28 Sept 2023 | | STX | REX Retail Offer | Shield Therapeutics PLC | RNS |
| 28/09/23 | STX | 07:01:02 | 28 Sept 2023 | | STX | $20m secured debt facility &proposed equity raise | Shield Therapeutics PLC | RNS |
| 28/09/23 | STX | 07:00:10 | 28 Sept 2023 | | STX | Interim results update and business update | Shield Therapeutics PLC | RNS |
| 06/09/23 | STX | 07:00:06 | 6 Sept 2023 | | STX | Notice of Results and Change in reporting currency | Shield Therapeutics PLC | RNS |
| 24/07/23 | STX | 14:27:13 | 24 Jul 2023 | | STX | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 20/07/23 | STX | 07:00:06 | 20 Jul 2023 | | STX | Business Update and U.S. Q2 2023 Highlights | Shield Therapeutics PLC | RNS |
| 28/06/23 | STX | 17:30:01 | 28 Jun 2023 | | STX | Results of 2023 Annual General Meeting | Shield Therapeutics PLC | RNS |
| 06/06/23 | STX | 10:10:00 | 6 Jun 2023 | | STX | Grant of share options to the CEO | Shield Therapeutics PLC | RNS |
| 01/06/23 | STX | 11:00:01 | 1 Jun 2023 | | STX | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 01/06/23 | STX | 10:55:01 | 1 Jun 2023 | | STX | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 31/05/23 | STX | 07:00:03 | 31 May 2023 | | STX | Total Voting Rights | Shield Therapeutics PLC | RNS |
| 19/05/23 | STX | 07:00:02 | 19 May 2023 | | STX | 2022 Annual Report and 2023 AGM Notice | Shield Therapeutics PLC | RNS |
| 18/05/23 | STX | 15:15:01 | 18 May 2023 | | STX | Form 8 (OPD) - Shield Therapeutics plc | Shield Therapeutics PLC | RNS |
| 09/05/23 | STX | 16:00:05 | 9 May 2023 | | STX | Rule 2.9 Announcement and TVR Update | Shield Therapeutics PLC | RNS |
| 27/04/23 | STX | 07:00:06 | 27 Apr 2023 | | STX | Business Update and Unaudited Results | Shield Therapeutics PLC | RNS |
| 12/04/23 | STX | 07:00:06 | 12 Apr 2023 | | STX | Notice of Results | Shield Therapeutics PLC | RNS |
| 05/04/23 | STX | 07:00:03 | 5 Apr 2023 | | STX | Appointment of Chief Commercial Officer | Shield Therapeutics PLC | RNS |
| 31/03/23 | STX | 07:00:10 | 31 Mar 2023 | | STX | Block Listing 6 Monthly Return | Shield Therapeutics PLC | RNS |
| 15/03/23 | STX | 16:35:08 | 15 Mar 2023 | | STX | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 28/02/23 | STX | 07:00:05 | 28 Feb 2023 | | STX | Total Voting Rights Update | Shield Therapeutics PLC | RNS |
| 17/02/23 | STX | 11:05:36 | 17 Feb 2023 | | STX | Second Price Monitoring Extn | Shield Therapeutics PLC | RNS |
